| POLY(ALLYLAMINE) |
聚（烯丙胺·盐酸） |
30551-89-4 |
| TCID |
4,5,6,7-四氯茚满-1,3-二酮 |
30675-13-9 |
| 4-Nitrophenyl-beta-D-galactopyranoside |
4-硝基苯基-D-吡喃葡糖苷 |
3150-24-1 |
| Arecoline hydrobromide |
氢溴酸槟榔碱 |
300-08-3 |
| K-Ras(G12C) inhibitor 6 |
K-RAS(G12C)抑制剂6 |
2060530-16-5 |
| ISRIB (trans-isoMer) |
ISRIB(TRANS-ISOMER) 抑制剂 |
1597403-47-8 |
| GSK J4 HCl |
N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸乙酯 |
1373423-53-0 |
| YH239-EE |
[N/A] |
1364488-67-4 |
| OG-L002 |
OG-L002 |
1357302-64-7 |
| CEP-33779 |
N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲磺酰基)苯基]-[1,2,4]三唑并[1,5-A]吡啶-2-胺 |
1346168-57-7 |
| ENMD-2076 (Tartrate) |
ENMD-2076 |
1291074-87-7 |
| WS6 |
WS6 |
1421227-53-3 |
| CX6258(HCL) |
CX-6258HCL |
1353859-00-3 |
| 5-[2,4-Dihydroxy-6-(4-nitrophenoxy)phenyl]-N-(1-methyl-4-piperidinyl)-3-isoxazolecarboxamide |
NMS-E973 |
1253584-84-7 |
| Aurora A Inhibitor I |
Aurora A Inhibitor I |
1158838-45-9 |
| PF-04217903 |
4-[1-(6-喹啉基甲基)-1H-1,2,3-三唑并[4,5-B]吡嗪-6-基]-1H-吡唑-1-乙醇 4-羟基苯磺酸盐 |
1159490-85-3 |
| BI-97C1 |
SABUTOCLAX |
1228108-65-3 |
| BS-181 hydrochloride |
N5-(6-氨基己基)-3-异丙基-N7-苄基吡唑并[1,5-A]嘧啶-5,7-二胺 |
1092443-52-1 |
| KX2-391 |
5-[4-[2-(4-吗啉基)乙氧基]苯基]-N-(苯基甲基)-2-吡啶乙酰胺盐酸盐 |
1038395-65-1 |
| GW791343 (HCl) |
GW791343 (HCL) |
1019779-04-4 |
